Publications for David Sullivan
Publications for David Sullivan
ES.114.001235">[More Information]</a>
2016
Nestel, P., Clifton, P., Colquhoun, D., Noakes,
M., Mori, T., Sullivan, D., Thomas, B. (2015).
Indications for Omega-3 Long Chain
Polyunsaturated Fatty Acid in the Prevention and
Treatment of Cardiovascular Disease. Heart,
Lung and Circulation, 24(8), 769-779. <a
href="http://dx.doi.org/10.1016/j.hlc.2015.03.02
0">[More Information]</a>
Hague, W., Simes, R., Kirby, A., Keech, A.,
White, H., Hunt, D., Nestel, P., Colquhoun, D.,
Pater, H., Stewart, R., Sullivan, D., et al (2016).
Long-Term Effectiveness and Safety of
Pravastatin in Patients With Coronary Heart
Disease: 16 Years of Follow-Up of the LIPID
Study. Circulation, 133(19), 1851-1860. <a
href="http://dx.doi.org/10.1161/CIRCULATION
AHA.115.018580">[More Information]</a>
Williams, K., Sullivan, D., Veillard, A., O'Brien,
R., George, J., Jenkins, A., Young, S., Ehnholm,
C., Duffield, A., Twigg, S., Keech, A. (2016).
Low alanine aminotransferase levels and higher
number of cardiovascular events in people with
Type 2 diabetes: analysis of the Fenofibrate
Intervention and Event Lowering in Diabetes
(FIELD) study. Diabetic Medicine, 33(3),
356-364. <a
href="http://dx.doi.org/10.1111/dme.12972">[M
ore Information]</a>
Williams, K., Sullivan, D., Nicholson, G.,
George, J., Jenkins, A., Januszewski, A., Gebski,
V., Manning, P., Tan, Y., Donoghoe, M., Buizen,
L., Twigg, S., Keech, A., et al (2016). Opposite
associations between alanine aminotransferase
and γ-glutamyl transferase levels and all-cause
mortality in type 2 diabetes: Analysis of the
Fenofibrate Intervention and Event Lowering in
Diabetes (FIELD) study. Metabolism: Clinical
and Experimental, 65(5), 783-793. <a
href="http://dx.doi.org/10.1016/j.metabol.2015.1
2.008">[More Information]</a>
2015
Tonkin, A., Blankenberg, S., Kirby, A., Zeller,
T., Colquhoun, D., Funke-Kaiser, A., Hague, W.,
Hunt, D., Keech, A., Nestel, P., Sullivan, D.,
Simes, R., et al (2015). Biomarkers in stable
coronary heart disease, their modulation and
cardiovascular risk: The LIPID biomarker study.
International Journal of Cardiology, 201,
499-507. <a
href="http://dx.doi.org/10.1016/j.ijcard.2015.07.
080">[More Information]</a>
Peiris, D., Usherwood, T., Panaretto, K., Harris,
M., Hunt, J., Redfern, J., Zwar, N., Colagiuri, S.,
Hayman, N., Lo, S., Patel, B., Lyford, M.,
MacMahon, S., Neal, B., Sullivan, D., Patel, A.,
et al (2015). Effect of a computer-guided, quality
improvement program for cardiovascular disease
risk management in primary health care: the
treatment of cardiovascular risk using electronic
decision support cluster-randomized trial.
Circulation. Cardiovascular Quality and
Outcomes, 8(1), 87-95. <a
href="http://dx.doi.org/10.1161/CIRCOUTCOM
Watts, G., Gidding, S., Wierzbicki, A., Toth, P.,
Alonso, R., Brown, W., Bruckert, E., Defesche,
J., Lin, K., Livingston, M., Sullivan, D., et al
(2015). Integrated guidance on the care of
familial hypercholesterolaemia from the
International FH Foundation. European Journal
of Preventive Cardiology, 22(7), 849-854. <a
href="http://dx.doi.org/10.1177/2047487314533
218">[More Information]</a>
Raal, F., Stein, E., Dufour, R., Turner, T.,
Civeira, F., Burgess, L., Langslet, G., Scott, R.,
Olsson, A., Sullivan, D., et al (2015). PCSK9
inhibition with evolocumab (AMG 145) in
heterozygous familial hypercholesterolaemia
(RUTHERFORD-2): a randomised,
double-blind, placebo-controlled trial. The
Lancet, 385(9965), 331-340. <a
href="http://dx.doi.org/10.1016/S0140-6736(14)
61399-4">[More Information]</a>
Ong, K., Januszewski, A., O'Connell, R., Buizen,
L., Jenkins, A., Xu, A., Sullivan, D., Barter, P.,
Scott, R., Taskinen, M., Rye, K., Keech, A.
(2015). Relationship of fibroblast growth factor
21 with baseline and new on-study microvascular
disease in the Fenofibrate Intervention and Event
Lowering in Diabetes study. Diabetologia, 59(8),
2035-2044. <a
href="http://dx.doi.org/10.1007/s00125-015-365
2-2">[More Information]</a>
Herrmann, M., Sullivan, D., Veillard, A.,
McCorquodale, T., Straub, I., Scott, R., Laakso,
M., Topliss, D., Jenkins, A., Blankenberg, S.,
Keech, A., et al (2015). Serum 25-Hydroxy
Vitamin D: A Predictor of Macrovascular and
Microvascular Complications in Patients With
Type 2 Diabetes. Diabetes Care, 38(3), 521-528.
<a
href="http://dx.doi.org/10.2337/dc14-0180">[M
ore Information]</a>
Pang, J., Sullivan, D., Harada-Shiba, M., Ding,
P., Selvey, S., Ali, S., Watts, G. (2015).
Significant gaps in awareness of familial
hypercholesterolemia among physicians in
selected Asia-Pacific countries: a pilot study.
Journal of Clinical Lipidology, 9(1), 42-48. <a
href="http://dx.doi.org/10.1016/j.jacl.2014.09.01
1">[More Information]</a>
Ong, K., Januszewski, A., O'Connell, R.,
Jenkins, A., Xu, A., Sullivan, D., Barter, P.,
Publications for David Sullivan
Hung, W., Scott, R., Taskinen, M., Keech, A.,
Rye, K. (2015). The relationship of fibroblast
growth factor 21 with cardiovascular outcome
events in the Fenofibrate Intervention and Event
Lowering in Diabetes study. Diabetologia, 58(3),
464-473. <a
href="http://dx.doi.org/10.1007/s00125-014-345
8-7">[More Information]</a>
Rosenson, R., Dent, R., Xue, A., Scott, R.,
Wasserman, S., Stroes, E. (2014). Design and
Rationale of the GAUSS-2 Study Trial: a
Double-Blind, Ezetimibe-Controlled Phase 3
Study of the Efficacy and Tolerability of
Evolocumab (AMG 145) in Subjects with
Hypercholesterolemia Who Are Intolerant of
Statin Therapy. Clinical Cardiology.
2014
Hinchcliffe, M., Le, H., Fimmel, A., Molloy, L.,
Freeman, L., Sullivan, D., Trent, R. (2014).
Diagnostic validation of a familial
hypercholesterolaemia cohort provides a model
for using targeted next generation DNA
sequencing in the clinical setting. Pathology,
46(1), 60-68. <a
href="http://dx.doi.org/10.1097/PAT.000000000
0000026">[More Information]</a>
Purchase, S., Vickery, A., Garton-Smith, J.,
O’Leary, P., Sullivan, D., Slattery, M., Playford,
D., Watts, G. (2014). A framework for bridging
the gap in the care of familial
hypercholesterolaemia in the community:
pragmatic and economic perspectives.
International Journal of Evidence-Based
Healthcare, 12(4), 244-254. <a
href="http://dx.doi.org/10.1097/XEB.000000000
0000019">[More Information]</a>
Freeman, L., Sullivan, D., Molloy, L.,
Srinivasan, S., Perera, N. (2014). Adjustment to
a diagnosis of Homozygous Familial
Hypercholesterolaemia and decision making
regarding therapy in two unrelated families.
Heart, Lung and Circulation, 23(S2), e9-e10.
Stroes, E., Colquhoun, D., Sullivan, D., Civeira,
F., Rosenson, R., Watts, G., Bruckert, E., Cho,
L., Dent, R., Knusel, B., et al (2014).
Anti-PCSK9 Antibody Effectively Lowers
Cholesterol in Patients with Statin Intolerance:
The GAUSS-2 Randomized, Placebo-controlled
Phase 3 Clinical Trial of Evolocumab. Journal of
the American College of Cardiology, 63(23),
2541-2548. <a
href="http://dx.doi.org/10.1016/j.jacc.2014.03.01
9">[More Information]</a>
White, H., Tonkin, A., Simes, R., Stewart, R.,
Mann, K., Thompson, P., Colquhoun, D., West,
M., Nestel, P., Sullivan, D., Keech, A., et al
(2014). Association of Contemporary Sensitive
Troponin I Levels at Baseline and Change at 1
Year With Long - Term Coronary Events
Following Myocardial Infarction or Unstable
Angina. Journal of the American College of
Cardiology, 63(4), 345-354. <a
href="http://dx.doi.org/10.1016/j.jacc.2013.08.16
43">[More Information]</a>
Kapellas, K., Jamieson, L., Do, L., Bartold, P.,
Wang, H., Maple-Brown, L., Sullivan, D.,
O'Dea, K., Brown, A., Celermajer, D., Skilton,
M., et al (2014). Associations between
periodontal disease and cardiovascular surrogate
measures among Indigenous Australians.
International Journal of Cardiology, 173(2),
190-196. <a
href="http://dx.doi.org/10.1016/j.ijcard.2014.02.
015">[More Information]</a>
Cho, L., Rocco, M., Colquhoun, D., Sullivan, D.,
Kapellas, K., Maple-Brown, L., Jamieson, L.,
Do, L., O'Dea, K., Brown, A., Cai, T., Anstey,
N., Sullivan, D., Wang, H., Celermajer, D.,
Skilton, M., et al (2014). Effect of Periodontal
Therapy on Arterial Structure and Function
Among Aboriginal Australians: A Randomized,
Controlled Trial. Hypertension, 64(4), 702-708.
<a
href="http://dx.doi.org/10.1161/HYPERTENSIO
NAHA.114.03359">[More Information]</a>
Stein, E., Giugliano, R., Koren, M., Raal, F.,
Roth, E., Weiss, R., Sullivan, D., Wasserman, S.,
Somaratne, R., Kim, J., et al (2014). Efficacy and
safety of evolocumab (AMG 145), a fully human
monoclonal antibody to PCSK9, in
hyperlipidaemic patients on various background
lipid therapies: pooled analysis of 1359 patients
in four phase 2 trials. European Heart Journal,
35(33), 2249-2259. <a
href="http://dx.doi.org/10.1093/eurheartj/ehu085
">[More Information]</a>
Watts, G., Gidding, S., Wierzbicki, A., Toth, P.,
Rodrigo, A., Brown, W., Bruckert, E., Defesche,
J., Lin, K., Livingston, M., Sullivan, D., et al
(2014). Integrated guidance on the care of
familial hypercholesterolaemia from the
International FH Foundation. International
Journal of Cardiology, 171(3), 309-325. <a
href="http://dx.doi.org/10.1016/j.ijcard.2013.11.
025">[More Information]</a>
Watts, G., Gidding, S., Wierzbicki, A., Toth, P.,
Alonso, R., Brown, W., Bruckert, E., Defesche,
J., Lin, K., Livingston, M., Sullivan, D., et al
(2014). Integrated guidance on the care of
familial hypercholesterolemia from the
International FH Foundation. Journal of Clinical
Lipidology, 8(2), 148-172. <a
href="http://dx.doi.org/10.1016/j.jacl.2014.01.00
2">[More Information]</a>
Samman, S., Crossett, B., Somers, M., Bell, K.,
Lai, N., Sullivan, D., Petocz, P. (2014).
Publications for David Sullivan
Metabolic profiling of plasma amino acids shows
that histidine increases following the
consumption of pork. Diabetes, Metabolic
Syndrome and Obesity: Targets and Therapy, 7,
203-210. <a
href="http://dx.doi.org/10.2147/DMSO.S60382"
>[More Information]</a>
Funke-Kaiser, A., Mann, K., Colquhoun, D.,
Zeller, T., Hunt, D., Simes, R., Sullivan, D.,
Sydow, K., West, M., White, H., et al (2014).
Midregional proadrenomedullin and its change
predicts recurrent major coronary events and
heart failure in stable coronary heart disease
patients: the LIPID study. International Journal
of Cardiology, 172(2), 411-418. <a
href="http://dx.doi.org/10.1016/j.ijcard.2014.01.
064">[More Information]</a>
Molloy, L., Freeman, L., Williams, G., Dunlop,
K., Sullivan, D. (2014). The RPAH experience of
improving resources for informing and
evaluating cascade screening in Familial
Hypercholesterolaemia. Heart, Lung and
Circulation, 23(S2), e14.
Rashid, I., Klimis, H., Duflou, J., Sullivan, D.,
Puranik, R. (2014). Utility of post-mortem lipid
levels in fatal premature CAD: An autopsy study.
International Journal of Cardiology, 174(1),
212-214. <a
href="http://dx.doi.org/10.1016/j.ijcard.2014.03.
196">[More Information]</a>
2013
White, H., Simes, R., Stewart, R., Blankenberg,
S., Barnes, E., Marschner, I., Thompson, P.,
West, M., Zeller, T., Colquhoun, D., Keech, A.,
Sullivan, D., et al (2013). Changes in
lipoprotein-associated phospholipase A2 activity
predict coronary events and partly account for
the treatment effect of pravastatin: results from
the Long-Term Intervention with Pravastatin in
Ischemic Disease study. Journal of the American
Heart Association, 2(5), 1-12. <a
href="http://dx.doi.org/10.1161/JAHA.113.0003
60">[More Information]</a>
Hoyos, C., Sullivan, D., Liu, P. (2013). Effect of
CPAP on the metabolic syndrome: a randomised
sham-controlled study. Thorax, 68(6), 588-589.
<a
href="http://dx.doi.org/10.1136/thoraxjnl-2012-2
03074">[More Information]</a>
Martin, A., Coakley, J., Forbes, D., Sullivan, D.,
Watts, G. (2013). Familial
hypercholesterolaemia in children and
adolescents: A new paediatric model of care.
Journal of Paediatrics and Child Health, 49(4),
E263-E272. <a
href="http://dx.doi.org/10.1111/jpc.12036">[Mo
re Information]</a>
Boekholdt, S., Arsenault, B., Hovingh, G., Mora,
S., Pedersen, T., LaRosa, J., Welch, K.,
Amarenco, P., DeMicco, D., Tonkin, A.,
Sullivan, D., Kirby, A., et al (2013). Levels and
Changes of HDL Cholesterol and Apolipoprotein
A-I in Relation to Risk of Cardiovascular Events
Among Statin-Treated Patients: A
Meta-Analysis. Circulation, 128(14), 1504-1512.
<a
href="http://dx.doi.org/10.1161/CIRCULATION
AHA.113.002670">[More Information]</a>
Nestel, P., Barnes, E., Tonkin, A., Simes, R.,
Fournier, M., White, H., Colquhoun, D.,
Blankenberg, S., Sullivan, D. (2013). Plasma
Lipoprotein(a) Concentration Predicts Future
Coronary and Cardiovascular Events in Patients
With Stable Coronary Heart Disease.
Arteriosclerosis, Thrombosis, and Vascular
Biology, 33(12), 2902-2908. <a
href="http://dx.doi.org/10.1161/ATVBAHA.113.
302479">[More Information]</a>
Chan, K., O'Connell, R., Sullivan, D., Hoffmann,
L., Rajamani, K., Whiting, M., Donoghoe, M.,
Vanhala, M., Hamer, A., Yu, B., Stocker, R., Ng,
M., Keech, A. (2013). Plasma total bilirubin
levels predict amputation events in type 2
diabetes mellitus: the fenofibrate intervention
and event lowering in diabetes (field) study.
Diabetologia, 56(4), 724-736. <a
href="http://dx.doi.org/10.1007/s00125-012-281
8-4">[More Information]</a>
Hankey, G., Anderson, N., Ting, R., Veillard, A.,
Romo, M., Wosik, M., Sullivan, D., O'Connell,
R., Hunt, D., Keech, A. (2013). Rates and
predictors of risk of stroke and its subtypes in
diabetes: A prospective observational study.
Journal of Neurology, Neurosurgery and
Psychiatry, 84(3), 281-287. <a
href="http://dx.doi.org/10.1136/jnnp-2012-30336
5">[More Information]</a>
Lewis, B., Sullivan, D., Watts, G. (2013).
Thought for food: Clinical evidence for the
dietary prevention strategy in cardiovascular
disease. International Journal of Evidence-Based
Healthcare (online), 11(4), 330-336. <a
href="http://dx.doi.org/10.1111/1744-1609.1204
7">[More Information]</a>
2012
Watts, G., Sullivan, D., van Bockxmeer, F.,
Poplawski, N., Hamilton-Craig, I., Clifton, P.,
O'Brien, R., Bishop, W., George, P., Semsarian,
C., et al (2012). A New Model of Care for
Familial Hypercholesterolaemia: What is the
Role of Cardiology? Heart, Lung and
Circulation, 21(9), 543-550. <a
href="http://dx.doi.org/10.1016/j.hlc.2012.04.01
0">[More Information]</a>
McEwen, B., Phillips, C., Morel-Kopp, M., Yee,
Publications for David Sullivan
B., Sullivan, D., Ward, C., Tofler, G., Grunstein,
R. (2012). Diurnal changes and levels of fibrin
generation are not altered by continuous positive
airway pressure (CPAP) in obstructive sleep
apnoea (OSA). Journal of Thrombosis and
Haemostasis, 108(4), 701-709. <a
href="http://dx.doi.org/10.1160/TH12-04-0231"
>[More Information]</a>
Sullivan, D., Olsson, A., Scott, R., Kim, J., Xue,
A., Gebski, V., Wasserman, S., Stein, E. (2012).
Effect of a monoclonal antibody to PCSK9 on
low-density lipoprotein cholesterol levels in
statin-intolerant patients: the GAUSS
randomized trial. JAMA, 308(23), 2497-2506. <a
href="http://dx.doi.org/10.1001/jama.2012.25790
">[More Information]</a>
Phillips, C., McEwen, B., Morel-Kopp, M., Yee,
B., Sullivan, D., Ward, C., Tofler, G., Grunstein,
R. (2012). Effects of continuous positive airway
pressure on coagulability in obstructive sleep
apnoea: a randomised, placebo-controlled
crossover study. Thorax, 67(7), 639-644. <a
href="http://dx.doi.org/10.1136/thoraxjnl-2011-2
00874">[More Information]</a>
Nik Tavakoli, N., Harris, A., Sullivan, D.,
Hambly, B., Bao, B. (2012). Interferon-g
deficiency reduces neointimal formation in a
model of endoluminal endothelial injury
combined with atherogenic diet. International
Journal of Molecular Medicine, 30(3), 545-552.
<a
href="http://dx.doi.org/10.3892/ijmm.2012.1034
">[More Information]</a>
Sullivan, D., Hamilton-Craig, I., van Bockxmeer,
F., Watts, G. (2012). INTERIM Guidelines for
the Diagnosis and Management of Familial
Hypercholesterolaemia. Heart, Lung and
Circulation, 21(3), 159-162. <a
href="http://dx.doi.org/10.1016/j.hlc.2011.11.00
6">[More Information]</a>
Ong, K., Rye, K., O'Connell, R., Jenkins, A.,
Brown, C., Xu, A., Sullivan, D., Barter, P.,
Keech, A. (2012). Long-Term Fenofibrate
Therapy Increases Fibroblast Growth Factor 21
and Retinol-Binding Protein 4 in Subjects with
Type 2 Diabetes. Journal of Clinical
Endocrinology and Metabolism, 97(12),
4701-4708. <a
href="http://dx.doi.org/10.1210/jc.2012-2267">[
More Information]</a>
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V.,
Neal, B. (2012). Omega 3 Fatty Acids and
Cardiovascular Outcomes: Systematic Review
and Meta-Analysis. Circulation. Cardiovascular
Quality and Outcomes, 5(6), 808-818. <a
href="http://dx.doi.org/10.1161/CIRCOUTCOM
ES.112.966168">[More Information]</a>
Herrmann, M., Whiting, M., Veillard, A.,
Ehnholm, C., Sullivan, D., Keech, A. (2012).
Plasma homocysteine and the risk of venous
thromboembolism: Insights from the FIELD
study. Clinical Chemistry and Laboratory
Medicine, 50(12), 2213-2219. <a
href="http://dx.doi.org/10.1515/cclm-2012-0078
">[More Information]</a>
2011
Sullivan, D., Lewis, B. (2011). A classification
of lipoprotein disorders: Implications for clinical
management. Clinical Lipidology, 6(3), 327-338.
Sullivan, D., Forder, P., Simes, R., Whiting, M.,
Kritharides, L., Merrifield, A., Donoghoe, M.,
Colman, P., Neil, G., Haapamäki, H., Keech, A.
(2011). Associations between the use of
metformin, sulphonylureas, or diet alone and
cardiovascular outcomes in 6005 patients with
type 2 diabetes in the FIELD study. Diabetes
Research and Clinical Practice, 94(2), 284-290.
<a
href="http://dx.doi.org/10.1016/j.diabres.2011.07
.028">[More Information]</a>
Phillips, C., Yee, B., Marshall, N., Liu, P.,
Sullivan, D., Grunstein, R. (2011). Continuous
Positive Airway Pressure Reduces Postprandial
Lipidemia in Obstructive Sleep Apnea. A
Randomised, Placebo Controlled Crossover
Trial. American Journal of Respiratory and
Critical Care Medicine, 184(3), 355-361. <a
href="http://dx.doi.org/10.1164/rccm.201102-03
16OC">[More Information]</a>
Watts, G., Sullivan, D., Poplawski, N., van
Bockxmeer, F., Hamilton-Craig, I., Clifton, P.,
O'Brien, R., Bishop, W., George, P., Barter, P.,
Freeman, L., Krass, I., Trent, R., et al (2011).
Familial hypercholesterolaemia: A model of care
for Australasia. Atherosclerosis Supplements, 12,
221-263. <a
href="http://dx.doi.org/10.1016/j.atherosclerosiss
up.2011.06.001">[More Information]</a>
Perera, N., Lewis, B., Tran, H., Fietz, M.,
Sullivan, D. (2011). Refsum's Disease-Use of the
Intestinal Lipase Inhibitor, Orlistat, as a Novel
Therapeutic Approach to a Complex Disorder.
Journal of Obesity, 2011 (482021). <a
href="http://dx.doi.org/10.1155/2011/482021">[
More Information]</a>
2010
Simes, R., Voysey, M., O'Connell, R., Glasziou,
P., Best, J., Scott, R., Pardy, C., Byth Wilson, K.,
Sullivan, D., Ehnholm, C., Keech, A. (2010). A
novel method to adjust efficacy estimates for
uptake of other active treatments in long-term
clinical trials. PloS One, 5(1), e8580-1-e8580-10.
<a
href="http://dx.doi.org/10.1371/journal.pone.000
8580">[More Information]</a>
Publications for David Sullivan
Taskinen, M., Barter, P., Ehnholm, C., Sullivan,
D., Mann, K., Simes, R., Best, J., Hamwood, S.,
Keech, A. (2010). Ability of traditional lipid
ratios and apolipoprotein ratios to predict
cardiovascular risk in people with type 2
diabetes. Diabetologia, 53(9), 1846-1855. <a
href="http://dx.doi.org/10.1007/s00125-010-180
6-9">[More Information]</a>
Perera, N., Burns, J., Perera, R., Lewis, B.,
Sullivan, D. (2010). Adjustment of direct
high-density lipoprotein cholesterol
measurements according to intercurrent
triglyceride corrects for interference by
triglyceride-rich lipoproteins. Journal of Clinical
Lipidology, 4(4), 305-309. <a
href="http://dx.doi.org/10.1016/j.jacl.2010.04.00
2">[More Information]</a>
Al-Sarraf, A., Al-Ghofaili, K., Sullivan, D.,
Wasan, K., Hegele, R., Frohlich, J. (2010).
Complete Apo AI deficiency in an Iraqi
Mandaean family: case studies and review of the
literature. Journal of Clinical Lipidology, 4(5),
420-426. <a
href="http://dx.doi.org/10.1016/j.jacl.2010.05.00
1">[More Information]</a>
Arya, F., Egger, S., Colquhoun, D., Sullivan, D.,
Pal, S., Egger, G. (2010). Differences in
postprandial inflammatory responses to a
'modern' v. traditional meat meal: a preliminary
study. British Journal of Nutrition, 104(5),
724-728. <a
href="http://dx.doi.org/10.1017/S000711451000
1042">[More Information]</a>
Webster, R., Webster, R., Li, S., Li, S., Sullivan,
D., Sullivan, D., Su, S., Su, S., Jayne, K., Jayne,
K., Neal, B., Neal, B. (2010). Effects Of
Internet-Based Tailored Advice on the Use of
Cholesterol-Lowering Interventions: A
Randomized Controlled Trial. Journal of
Medical Internet Research, 12(3), 1-13. <a
href="http://dx.doi.org/10.2196/jmir.1364">[Mor
e Information]</a>
Puranik, R., Puranik, R., Fox, O., Fox, O.,
Sullivan, D., Sullivan, D., Duflou, J., Duflou, J.,
Bao, B., Bao, B. (2010). Inflammatory
characteristics of premature coronary artery
disease. International Journal of Cardiology,
145(2), 288-290. <a
href="http://dx.doi.org/10.1016/j.ijcard.2009.10.
029">[More Information]</a>
Booth, M., Dobbins, T., Aitken, R.,
Denney-Wilson, E., Hardy, L., Okely, A.,
George, J., Sullivan, D., Cowell, C. (2009). Costs
of managing conditions associated with obesity
among Australian teenagers. Journal of
Paediatrics and Child Health, 45(7-8), 448-456.
<a
href="http://dx.doi.org/10.1111/j.1440-1754.200
9.01503.x">[More Information]</a>
Ayer, J., Sullivan, D., Sholler, G. (2009). Lipid
abnormalities in children: should we be doing
more? Medical Journal of Australia, 190(3),
107-108. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19203302">[More Information]</a>
Watts, G., Hamilton-Craig, I., Sullivan, D.
(2009). NICE Guidance on Familial
Hypercholesterolaemia: All Sugar and Spice?
Heart, Lung and Circulation, 18(3), 181-183. <a
href="http://dx.doi.org/10.1016/j.hlc.2008.10.01
2">[More Information]</a>
Taskinen, M., Sullivan, D., Ehnholm, C.,
Whiting, M., Zannino, D., Simes, R., Keech, A.,
Barter, P. (2009). Relationships of HDL
cholesterol, ApoA-I, and ApoA-II with
homocysteine and creatinine in patients with
Type 2 diabetes treated with fenofibrate.
Arteriosclerosis, Thrombosis, and Vascular
Biology, 29(6), 950-955. <a
href="http://dx.doi.org/10.1161/ATVBAHA.108.
178228">[More Information]</a>
Kluger, E., Hardman, C., Govendir, M., Baral,
R., Sullivan, D., Snow, D., Malik, R. (2009).
Triglyceride response following an oral fat
tolerance test in Burmese cats, other pedigree
cats and domestic crossbred cats. Journal of
Feline Medicine and Surgery, 11(2), 82-90. <a
href="http://dx.doi.org/10.1016/j.jfms.2008.05.0
05">[More Information]</a>
2008
Wlodarzcyk, J., Smith, M., Sullivan, D. (2008).
Assessment and Quantification of the Benefit
Risk Ratio of Rosuvastatin and Atorvastatin from
a Meta-Analysis of Head to Head Randomised
Controlled Trials. Value in Health, 11(3),
A188-A189.
Lewis, B., Watts, G., Sullivan, D. (2010). On
Reducing Cardiovascular Disease to a Rarity:
Clinical Strategies and their Cost-Effectiveness.
Heart, Lung and Circulation, 19(4), 225-227. <a
href="http://dx.doi.org/10.1016/j.hlc.2010.01.00
2">[More Information]</a>
Wlodarczyk, J., Sullivan, D., Smith, M. (2008).
Comparison of benefits and risks of rosuvastatin
versus atorvastatin from a meta-analysis of
head-to-head randomized controlled trials. The
American Journal of Cardiology, 102(12),
1654-1662. <a
href="http://dx.doi.org/10.1016/j.amjcard.2008.0
8.014">[More Information]</a>
2009
Tavakoli, N., Hambly, B., Sullivan, D., Bao, S.
(2008). Forkhead box protein 3: Essential
Publications for David Sullivan
immune regulatory role. The International
Journal of Biochemistry and Cell Biology,
40(11), 2369-2373. <a
href="http://dx.doi.org/10.1016/j.biocel.2007.10.
004">[More Information]</a>
Homer, V., Marais, A., Charlton, F., Laurie, A.,
Hurndell, N., Scott, R., Mangili, F., Sullivan, D.,
Barter, P., Rye, K., et al (2008). Identification
and characterization of two non-secreted PCSK9
mutants associated with familial
hypercholesterolemia in cohorts from New
Zealand and South Africa. Atherosclerosis,
196(2), 659-666. <a
href="http://dx.doi.org/10.1016/j.atherosclerosis.
2007.07.022">[More Information]</a>
Lambert, G., Ancellin, N., Charlton, F., Comas,
D., Pilot, J., Keech, A., Patel, S., Sullivan, D.,
Cohn, J., Rye, K., Barter, P. (2008). Plasma
PCSK9 Concentrations Correlate with LDL and
Total Cholesterol in Diabetic Patients and Are
Decreased by Fenofibrate Treatment. Clinical
Chemistry, 54(6), 1038-1045. <a
href="http://dx.doi.org/10.1373/clinchem.2007.0
99747">[More Information]</a>
Tognarini, D., Sullivan, D., Thomas, D., Sikaris,
K. (2008). Reducing CVD risk - integration of
clinical and laboratory criteria. Australian
Family Physician, 37(6), 422-427.
Jones, G., McNeil, A., Stewart, P., Sullivan, D.,
Vasikaran, S., Barker, A., DeVoss, K., Badrick,
T., Chiu, W., Royal College of Pathologists of
Australasia, (., et al (2008). Royal College of
Pathologists of Australasia (RCPA) and
Australasian Association of Clinical Biochemists
(AACB) Position Statement on Impaired Fasting
Glucose. Pathology, 40(6), 627-628.
Kluger, E., Malik, R., Ilkin, W., Snow, D.,
Sullivan, D., Govendir, M. (2008). Serum
triglyceride concentration in dogs with epilepsy
treated with phenobarbital or with phenobarbital
and bromide. Journal of the American Veterinary
Medical Association, 233(8), 1270-1277. <a
href="http://dx.doi.org/10.2460/javma.233.8.127
0">[More Information]</a>
Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R.,
Sullivan, D., Celermajer, D., Neal, B. (2008).
Significant lipid, adiposity and metabolic
abnormalities amongst 4535 Indians from a
developing region of rural Andhra Pradesh.
Atherosclerosis, 196, 943-952. <a
href="http://dx.doi.org/10.1016/j.atherosclerosis.
2007.02.027">[More Information]</a>
Brown, A., Lattimore, J., McGrady, M., Sullivan,
D., Dyer, W., Braet, F., Dos Remedios, C.
(2008). Stable and unstable angina: Identifying
novel markers on circulating leukocytes.
Proteomics - Clinical Applications, 2, 90-98. <a
href="http://dx.doi.org/10.1002/prca.200780090"
>[More Information]</a>
West, M., Nestel, P., Kirby, A., Schnabel, R.,
Sullivan, D., Simes, R., Pollicino, C., Lubos, E.,
Munzel, T., White, H., et al (2008). The value of
N-terminal fragment of brain natriuretic peptide
and tissue inhibitor of metalloproteinase-1 levels
as predictors of cardiovascular outcome in the
LIPID study. European Heart Journal, 29(7),
923-931. <a
href="http://dx.doi.org/10.1093/eurheartj/ehn007
">[More Information]</a>
2007
Watts, G., Lewis, B., Sullivan, D. (2007).
Familial hypercholesterolemia: a missed
opportunity in preventive medicine. Nature
Clinical Practice Cardiovascular Medicine, 4(8),
404-405. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17593912">[More Information]</a>
Tavakoli, N., Hambly, B., Sullivan, D., Bao, B.
(2007). Forkhead box protein 3: Essential
immune regulatory role. The International
Journal of Biochemistry and Cell Biology,
doi:10.1016/j.biocel.2007.10.004(40 (11)),
2369-2373. <a
href="http://dx.doi.org/10.1016/j.biocel.2007.10.
004">[More Information]</a>
Emery, J., Barlow-Stewart, K., Metcalfe, S.,
Sullivan, D. (2007). Genetics and preventive
health care. Australian Family Physician, 36(10),
808-11. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17925900">[More Information]</a>
Sullivan, D. (2007). Guidelines for the diagnosis
and management of familial
hypercholesterolaemia. Heart, Lung and
Circulation, 16(1), 25-7. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17188936">[More Information]</a>
Homer, V., Marais, A., Laurie, A., Charlton, F.,
Sullivan, D., Barter, P., Rye, K., George, P.,
Lambert, G. (2007). Identification and Molecular
Characterization of New PCSK9 Missense
Mutations Associated with Familial
Hypercholesterolemia. Arteriosclerosis,
Thrombosis, and Vascular Biology, 27(6), e-122.
Sullivan, D., Thomas, D., Tognarini, D. (2007).
Rationale for recommendations for lipid testing
and reporting by Australian pathology
laboratories. Clinical Biochemist Reviews, 28(2),
46-49. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17687414">[More Information]</a>
Publications for David Sullivan
Appleton, C., Caldwell, G., McNeil, A.,
Meerkin, M., Sikaris, K., Sullivan, D., Thomas,
D., Tognarini, D. (2007). Recommendations for
lipid testing and reporting by Australian
pathology laboratories. Clinical Biochemist
Reviews, 28(2), 32-45. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17687413">[More Information]</a>
Skilton, M., Sieveking, D., Harmer, J., Franklin,
J., Loughnan, G., Nakhla, S., Sullivan, D.,
Caterson, I., Celermajer, D. (2007). The effects
of obesity and non-pharmacological weight loss
on vascular and ventricular function and
structure. Diabetes, Obesity and Metabolism,
10(10), 874-884. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18034845">[More Information]</a>
2006
Al-Mahdili, H., Hooper, A., Sullivan, D.,
Stewart, P., Burnett, J. (2006). A mild case of
abetalipoproteinaemia in association with
subclinical hypothyroidism. Annals of Clinical
Biochemistry, 43, 516-519. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17132287">[More Information]</a>
Le Couteur, D., Cogger, V., Hilmer, S., Muller,
M., Harris, M., Sullivan, D., McLean, A., Fraser,
R. (2006). Aging, atheroscleroisis and the liver
sieve. In Clarke, Leon V (Eds.), New research
on atherosclerosis, (pp. 19-44). New York: Nova
Science Publishers.
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2006). Clinical biochemistry and metabolism.
In NA Boon, NR Colledge, BR Walker, JAA
Hunter (Eds.), Davidson's Principles & Practice
of Medicine, (pp. 419-454). Edinburgh: Churchill
Livingstone.
Tapsell, L., Hemphill, I., Cobiac, L., Sullivan,
D., Fenech, M., Patch, C., Keogh, J., Clifton, P.,
Williams, P., Inge, K. (2006). Health benefits of
herbs and spices: the past, the present, the future.
Medical Journal of Australia, 185(4), S4-S24. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17022438">[More Information]</a>
Cogger, V., Hilmer, S., Sullivan, D., Muller, M.,
Fraser, R., Le Couteur, D. (2006).
Hyperlipidemia and surfactants: The liver sieve
is a link. Atherosclerosis, 189, 273-281. <a
href="http://dx.doi.org/10.1016/j.atherosclerosis.
2005.12.025">[More Information]</a>
Lau, G., Ridley, L., Bannon, P., Freedman, B.,
Brieger, D., Sullivan, D., Wong, L., Kritharides,
L. (2006). Hypertriglyceridaemia is associated
with early non-patency of coronary bypass
grafts. Heart, 92(4), 536-538. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16537772">[More Information]</a>
Sullivan, D., Forder, P., Simes, R., Whiting, M.,
Keech, A. (2006). Individual and combined
effects of fenofibrate and sulphonylureas on
HDL cholesterol and outcomes. XIV
International Symposium on Atherosclerosis,
Ireland: Elsevier Ireland Ltd.
Stocker, R., Pollicino, C., Gay, C., Nestel, P.,
Colquhoun, D., Whiting, M., Tonkin, A.,
Sullivan, D., Simes, R. (2006). Neither plasma
coenzyme Q(10) concentration, nor its decline
during pravastatin therapy, is linked to recurrent
cardiovascular disease events: A prospective
case-control study from the LIPID study.
Atherosclerosis, 187(1), 198-204. <a
href="http://dx.doi.org/10.1016/j.atherosclerosis.
2005.09.004">[More Information]</a>
May, J., Abraham, N., Sullivan, D., White, G.,
Harris, J. (2006). Previously underestimated
incidence of subclinical myocardial damage: A
prospective concurrent comparison of
endovascular versus open repair of infrarenal
AAA. 19th International Congress on
Endovascular Interventions, United states:
Alliance Communication Group.
Tulloh, L., Robinson, D., Patel, A., Ware, A.,
Prendergast, C., Sullivan, D., Pressley, L. (2006).
Raised troponin T and echocardiographic
abnormalities after prolonged strenuous
exercise--the Australian Ironman Triathlon.
British Journal of Sports Medicine, 40(7),
605-609. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16611724">[More Information]</a>
2005
Abraham, N., Lemech, L., Sandroussi, C.,
Sullivan, D., May, J. (2005). A prospective study
of subclinical myocardial damage in
endovascular versus open repair of infrarenal
abdominal aortic aneurysms. Journal Of
Vascular Surgery, 41(3), 377-380. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15838465">[More Information]</a>
Hilmer, S., Cogger, V., Fraser, R., McLean, A.,
Sullivan, D., Le Couteur, D. (2005). Age-related
changes in the hepatic sinusoidal endothelium
impede lipoprotein transfer in the rat.
Hepatology, 42(6), 1349-1354. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16317689">[More Information]</a>
Publications for David Sullivan
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2005). Biochemical Disorders. In N Boon, N
Colledge, B Walker, J Hunter (Eds.), Davidson's
Principles and Practice of Medicine (20 Ed.),
(pp. 1-2). United Kingdom: Elsevier.
Field, M., Burnett, L., Sullivan, D., Stewart, P.
(2005). Clinical biochemistry and metabolism.
In Nicholas A. Boon, Nicki R. Colledge, Brian
R. Walker and John Hunter (Eds.), Davidson's
Principles and Practice of Medicine, (pp.
419-454). Churchill Livingstone.
Swinburn, B., Carey, D., Hills, A., Hooper, M.,
Marks, S., Proietto, J., Strauss, B., Sullivan, D.,
Welborn, T., Caterson, I. (2005). Effect of
orlistat on cardiovascular disease risk in obese
adults. Diabetes, Obesity and Metabolism, 7(3),
254-62. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15811142">[More Information]</a>
Keech, A., Simes, R., Barter, P., Best, J., Scott,
R., Taskinen, M., Forder, P., Pillai, A., Davis, T.,
Glasziou, P., Sullivan, D., MacMahon, S., et al
(2005). Effects of long-term fenofibrate therapy
on cardiovascular events in 9795 people with
type 2 diabetes mellitus (the FIELD study):
randomised controlled trial. The Lancet,
366(9500), 1849. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16310551">[More Information]</a>
Samra, J., Sved, P., Sullivan, D., Hugh, T.,
Smith, R. (2005). Lipid metabolism in omental
adipose tissue during operative surgery. Journal
of Surgical Research, 124(1), 23-28. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15734475">[More Information]</a>
Simons, L., Sullivan, D. (2005). Lipid-modifying
drugs. Medical Journal of Australia, 182(6),
286-289. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15777144">[More Information]</a>
Skilton, M., Lai, N., Griffiths, K., Molyneaux,
L., Yue, D., Sullivan, D., Celermajer, D. (2005).
Meal-related increases in vascular reactivity are
impaired in older and diabetic adults: insights
into roles of aging and insulin in vascular flow.
American Journal of Physiology: Heart and
Circulatory Physiology, 288(3), H1404-H1410.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15513964">[More Information]</a>
Tonkin, A., Barter, P., Best, J., Boyden, A.,
Furler, J., Hossack, K., Sullivan, D., Thompson,
P., Vale, M., Cooper, C., et al (2005). National
Heart Foundation of Australia and the Cardiac
Society of Australia and New Zealand: position
statement on lipid management--2005. Heart,
Lung and Circulation, 14(4), 275. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16361000">[More Information]</a>
Patel, A., Woodward, M., Campbell, D.,
Sullivan, D., Colman, S., Chalmers, J., Neal, B.,
MacMahon, S. (2005). Plasma lipids predict
myocardial infarction, but not stroke, in patients
with established cerebrovascular disease.
European Heart Journal, 26(18), 1910-1915. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16006443">[More Information]</a>
Sullivan, D. (2005). The clinical and nutritional
implications of lipid-lowering drugs that act in
the gastrointestinal tract. Current Opinion in
Lipidology, 16(1), 39-45. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15650562">[More Information]</a>
Sullivan, D., West, M., Jeremy, R. (2005). Utility
of Brain Natriuretic Peptide (BNP)
Measurement in Cardiovascular Disease. Heart,
Lung and Circulation, 14(2), 78-84. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16352258">[More Information]</a>
2004
Kockx, M., Rye, K., Gaus, K., Quinn, C.,
Wright, J., Sloane, T., Sviridov, D., Sullivan, D.,
Fu, Y., Burnett, J., Kritharides, L., et al (2004).
Apolipoprotein A-I-Stimulated Apolipoprotein E
Secretion From Human Macrophages Is
Independent Of Cholesterol Efflux. Journal of
Biological Chemistry, 279(25), 25966-25977.
Clifton, P., Noakes, M., Sullivan, D., Erichsen,
N., Ross, D., Annison, G., Fassoulakis, A.,
Cehun, M., Nestel, P. (2004).
Cholesterol-Lowering Effects Of Plant Sterol
Esters Differ In Milk, Yoghurt, Bread And
Cereal. European Journal of Clinical Nutrition,
58, 503-509.
Lai, N., Lyons-Wall, P., Samman, S., Sullivan,
D. (2004). Intake of Selected Phytochemicals
and Prevention of Coronary Heart Disease:
Practical Implications. In R. Nath, M. Khullar
and P. Singal (Eds.), Antioxidants and
Cardiovascular Disease, (pp. 194-202). New
Delhi, India: Narosa Publishing House.
Lau, G., Sullivan, D. (2004). Preoperative
hypertriglyceridemia is associated with early
occlusion of radial artery but not saphenous vein
coronary bypass grafts. Circulation, 110,
183-184.
Publications for David Sullivan
Hilmer, S., Warren, A., Cogger, V., Fraser, R.,
McLean, A., Sullivan, D., Le Couteur, D. (2004).
The Effect Of Aging On The
Immunohistochemistry Of Apolipoprotein E In
The Liver. Experimental Gerontology, 39(1),
53-57.
Sullivan, D., Celermajer, D., Le Couteur, D.,
Lam, C. (2004). The Vascular Implications Of
Postprandial Lipoprotein Metabolism. Clinical
Biochemist Reviews, 25(1), 19-30.
2003
Yen, T., Nightingale, B., Burns, J., Sullivan, D.,
Stewart, P. (2003). Butylcholinesterase (BCHE)
Genotyping for post-succinylcholine apnea in an
Australian population. Clinical Chemistry, 49(8),
1297-1308.
Nugent, A., Leung, K., Sullivan, D., Reutens, A.,
Ho, K. (2003). Modulation by progestogens of
the effects of oestrogen on hepatic endocrine
function in postmenopausal women. Clinical
Endocrinology, 59(6), 690-698.
Gatto, L., Sullivan, D., Samman, S. (2003).
Postprandial effects of dietary trans fatty acids
on apolipoprotein (a) and cholesterol ester
transfer. The American Journal of Clinical
Nutrition, 77(5), 1119-1124.
Sullivan, D. (2003). Recent trends in lipid
management: raising the bar and shifting the
goalposts? Internal Medicine Journal, 33(3),
95-102.
2002
Prasan, A., McCarron, H., Hambly, B., Fermanis,
G., Sullivan, D., Jeremy, R. (2002). Effect of
treatment on ventricular function and troponin I
proteolysis in reperfused myocardium. Journal of
Molecular and Cellular Cardiology, 34(4),
401-411. <a
href="http://dx.doi.org/10.1006/jmcc.2002.1522"
>[More Information]</a>
Simes, R., Marschner, I., Hunt, D., Sullivan, D.,
Colquhoun, D., Hague, W., Stewart, R., Keech,
A., Thompson, P., White, H., et al (2002).
Relationship between lipid levels and clinical
outcomes in the long-term intervention with
pravastatin in ischemic disease (LIPID) trial: to
what extent is the reduction in coronary events
with pravastatin explained by on-study lipid
levels? Circulation, 105(10), 1162-1169.
2001
Caterson, I., Carey, D., Hills, A., Hooper, M.,
Marks, S., Proietto, J., Strauss, B., Sullivan, D.,
Swinburn, B., Welborn, T. (2001). The
Australasian Orlistat Multi-Comorbidity Study.
10th Meeting of the Australasian Society for the
Study of Obesity, : Ads & Adea.
2000
Raitakari, O., McCredie, R., Letters, J., Witting,
P., Griffiths, K., Sullivan, D., Stocker, R.,
Celermajer, D. (2000). Coenzyme Q improves
LDL resistance to ex vivo oxidation but does not
enhance endothelial function in
hypercholesterolemic young adults. Free Radical
Biology and Medicine, 28, 1100-1105.
Mears, D., Chui, A., Stewart, P., Burns, J.,
Sullivan, D., Bowen, D., Sheil, A. (2000).
Lecithin Cholesterol Acyltransferase Activity
Following Orthotopic Liver Transplantation.
Transplantation Proceedings, 32(1), 169-170.
Raitakari, O., Lai, N., Griffiths, K., McCredie,
R., Sullivan, D., Celermajer, D. (2000).
Preserved endothelial function and enhanced
peripheral vasodilation in humans after a fatty
meal. Journal of the American College of
Cardiology, 36, 417-422.